Friday, 20 November 2026European Markets

MEDINCELL Stock Impressive Rise On Tuesday, Outperforms Market

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(vianews) - the market ended the session with medincell (medcl.pa) jumping 14.41% to €10.16 on tuesday, following the last session's downward trend. cac 40 slid 1.45% to €7,383.20, after two consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.

medincell's last close was €8.88, 14.29% below its 52-week high of €10.36.

about medincell

medincell s.a. develops various therapeutic solutions in france. it develops solutions based on bepo, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. the company's products in development include mdc-irm, a risperidone extended-release injectable suspension completed phase iii trial for use in the treatment of schizophrenia; mdc-cwm, a sustained-release formulation of celecoxib in phase iii trials for use in the treatment of reduction of postoperative pain & inflammation; and mdc-tjk, a subcutaneous injection in phase iii trials for use in the treatment of schizophrenia. its product candidates in preclinical trials, such as mdc-ang, an antipsychotic product for use in the treatment of schizophrenia; mdc-ttg for covid-19 and its variants; mdc-grt for use in organ transplant; mdc-wwm for contraception; mdc-stm for use in malaria; mdc-kpt for use in acute pain for pets; and mdc-irm for use in neuroscience. the company was incorporated in 2003 and is based in jacou, france.

earnings per share

as for profitability, medincell has a trailing twelve months eps of €-1.05.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, medincell's stock is considered to be oversold (<=20).

yearly top and bottom value

medincell's stock is valued at €10.16 at 22:35 est, below its 52-week high of €10.36 and way above its 52-week low of €4.73.

moving average

medincell's worth is way above its 50-day moving average of €8.92 and way higher than its 200-day moving average of €6.80.

volume

today's last reported volume for medincell is 541200 which is 1135.64% above its average volume of 43799.

more news about medincell (medcl.pa).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 2 May 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›